Latest News & Updates | Lymphoma Canada Announcements

News

Lymphoma: A Wake-up Call

For Anthony Liscio, a diagnosis of stage III Hodgkin lymphoma nine years ago was “a…

adminDecember 9, 2013

News

Celebrating a Friend

A year ago, if you saw Kristen Christie running, “there was either someone chasing me…

adminDecember 9, 2013

News

Bend All Automotive supports Lymphoma Canada

A heartfelt vote of thanks to Bend All Automotive in Ayr, Ontario and to the…

adminDecember 9, 2013

Press Releases

Lymphoma Canada Appoints Robin Markowitz CEO

Lymphoma Canada is pleased to announce the appointment of Robin Markowitz as Chief Executive Officer,…

adminNovember 21, 2013

Research

Y-ibritumomab tiuxetan and high-dose BEAM chemotherapy conditioning followed by autologous stem cell transplantation shows encouraging response and survival rates in refractory diffuse large B-cell lymphoma patients

Although combination rituximab and chemotherapy treatment has improved the survival of patients with diffuse large…

adminNovember 18, 2013

Research

Potential Role of Lymphocyte Development Gene Variants in Non-Hodgkin Lymphoma Risk

The risk of developing NHL can be influenced by both environmental and genetic factors that…

adminNovember 7, 2013

Research

Rituximab helps overcome adverse effects of diabetes mellitus for patients with diffuse large B-cell lymphoma.

Diabetes mellitus, also known colloquially just as diabetes, is a group of metabolic diseases in…

adminNovember 7, 2013

Research

LR11: a novel biomarker identified in follicular lymphoma

Follicular Lymphoma, or Fl, is the second most frequent type of non-Hodgkin lymphoma, and is…

adminSeptember 16, 2013

Research

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma

A study was recently been published with the objective to define the indications for hematopoietic…

adminSeptember 16, 2013

Research

Radioimmunotherapy treatment using 177Lu-DOTA-Rituximab shown to be both safe and feasible for Lymphoma patients

A study completed by Dr. Andreas Lohri and colleagues has shown that radioimmunotherapy treatment for…

adminSeptember 16, 2013

Mon	Tue	Wed	Thu	Fri	Sat	Sun
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

News & Media

Lymphoma: A Wake-up Call

Celebrating a Friend

Bend All Automotive supports Lymphoma Canada

Lymphoma Canada Appoints Robin Markowitz CEO

Y-ibritumomab tiuxetan and high-dose BEAM chemotherapy conditioning followed by autologous stem cell transplantation shows encouraging response and survival rates in refractory diffuse large B-cell lymphoma patients

Potential Role of Lymphocyte Development Gene Variants in Non-Hodgkin Lymphoma Risk

Rituximab helps overcome adverse effects of diabetes mellitus for patients with diffuse large B-cell lymphoma.

LR11: a novel biomarker identified in follicular lymphoma

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma

Radioimmunotherapy treatment using 177Lu-DOTA-Rituximab shown to be both safe and feasible for Lymphoma patients

Are you a patient?

Are you a healthcare professional?

Upcoming Events

Contact Us

Donate

Careers

Join Our Mailing List